Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 9—September 2007

HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan

Catherine S. Todd*, Abdullah M.S. Abed†, Steffanie A. Strathdee*, Paul T. Scott‡Comments to Author , Boulos A. Botros§, Naqibullah Safi†, and Kenneth C. Earhart§
Author affiliations: *University of California, San Diego, La Jolla, California, USA; †Ministry of Public Health, Kabul, Afghanistan; ‡Walter Reed Army Institute of Research, Rockville, Maryland, USA; §United States Naval Medical Research Unit 3, Cairo, Egypt;

Main Article


Factors independently associated with HCV infection (n = 170) by multivariable analysis in 463 male injection drug users, Kabul, Afghanistan*

Factor Value
HCV prevalence 107 (36.8)
Demographic factors
Married 0.60 (0.40–0.92)
Higher educational level 0.51 (0.29–0.88)
Drug practices
Ever shared needle or syringe 2.60 (1.71–3.96)
Duration injection drug use >3 y 3.28 (2.17–4.96)
Medical encounters
Injections by a nonmedical provider   2.71 (1.26–5.82)

*HCV, hepatitis C virus. Values are no. (%) or adjusted odds ratio (95% confidence interval). Analysis was adjusted for marital status, educational level, duration of injecting, sharing needles or syringes, and injections by a nonmedical provider.

Main Article

Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.